Literature DB >> 19669609

Biological characteristics of a specific brain metastatic cell line derived from human lung adenocarcinoma.

Ling Hu1, Junqing Zhang, Hongbin Zhu, Jie Min, Yingming Feng, Helong Zhang.   

Abstract

To study the expression of VEGF, MMP-9, EGFR, and S100B in a highly brain metastases sub-clone cell line, PC14/B. The in vitro metastases-related behaviors of PC14 /B cells, such as adhesion to extracellular matrix (ECM), migration, and invasion were determined and compared with primary PC14 cells and A549 cells that do not metastasize to brain. The expression of vascular epithelial growth factor (VEGF), matrix metalloproteinase 9 (MMP-9), S100B, and epidermal growth factor receptor (EGFR) in the above three cell lines were measured by immunohistochemical staining and Western blot assay.The PC14/B cells have enhanced abilities of adhesion, migration, and invasion than PC14 cells and A549 cells. The expression levels of VEGF and MMP-9 in PC14/B cells are much higher than in PC14 and A549 cells. Two protein polymers of S100B are expressed specially in PC14/B cells. The expression of EGFR has a significant lower level in PC14 cells than in the other two cell lines. The increased expression of VEGF and MMP-9 may lead to the enhancement of adhesion, migration, and invasion of PC14/B cells. The expression of EGFR in PC14/B cells may have negative correlation with their capacities of metastasizing to brain. The specific expression of S100B in PC14/B cells strongly suggest that S100B might be a potential target for developing new therapy to brain metastases of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669609     DOI: 10.1007/s12032-009-9273-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  29 in total

Review 1.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

2.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 3.  EGFR and cancer prognosis.

Authors:  R I Nicholson; J M Gee; M E Harper
Journal:  Eur J Cancer       Date:  2001-09       Impact factor: 9.162

4.  [Clinical analysis of combination therapy for 252 patients of lung cancer with brain metastasis].

Authors:  S Zhang; X Yang; A Zhao
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  1999-08

5.  Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability.

Authors:  Tae-Hee Lee; Hava Karsenty Avraham; Shuxian Jiang; Shalom Avraham
Journal:  J Biol Chem       Date:  2002-11-20       Impact factor: 5.157

6.  Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells.

Authors:  Jing Lin; Qingyuan Yang; Zhe Yan; Joseph Markowitz; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2004-06-03       Impact factor: 5.157

Review 7.  The organ microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

8.  [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].

Authors:  An-hui Shi; Guang-ying Zhu; Rong Yu; Hui-min Ma; Chang-qing Liu; Xing Su; Yan Sun; Yong Cai; Xiao-na Xu; Shan-wen Zhang; Bo Xu
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2007-07

Review 9.  Brain-metastatic melanoma: a neurotrophic perspective.

Authors:  Dario Marchetti; Yvonne Denkins; Jane Reiland; Andrea Greiter-Wilke; Jennifer Galjour; Brian Murry; Jason Blust; Madhuchhanda Roy
Journal:  Pathol Oncol Res       Date:  2003-10-07       Impact factor: 3.201

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  6 in total

1.  S100B protein as a possible participant in the brain metastasis of NSCLC.

Authors:  Xiaowen Pang; Jie Min; Lili Liu; Yi Liu; Ningqiang Ma; Helong Zhang
Journal:  Med Oncol       Date:  2012-12       Impact factor: 3.064

Review 2.  Zinc and zinc-containing biomolecules in childhood brain tumors.

Authors:  Jan Hrabeta; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Sona Krizkova; Vojtech Adam
Journal:  J Mol Med (Berl)       Date:  2016-09-16       Impact factor: 4.599

Review 3.  Lung cancer-associated brain metastasis: Molecular mechanisms and therapeutic options.

Authors:  Meysam Yousefi; Tayyeb Bahrami; Arash Salmaninejad; Rahim Nosrati; Parisa Ghaffari; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2017-09-18       Impact factor: 6.730

4.  Blood-brain Barrier Remodeling during Brain Metastasis Formation.

Authors:  Jagoda K Wrobel; Michal Toborek
Journal:  Mol Med       Date:  2016-01-13       Impact factor: 6.354

Review 5.  The Importance of Small Extracellular Vesicles in the Cerebral Metastatic Process.

Authors:  Flaviu Tămaș; Rodica Bălașa; Doina Manu; Gabriel Gyorki; Rareș Chinezu; Corina Tămaș; Adrian Bălașa
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

Review 6.  Role of the blood-brain barrier in the formation of brain metastases.

Authors:  Imola Wilhelm; Judit Molnár; Csilla Fazakas; János Haskó; István A Krizbai
Journal:  Int J Mol Sci       Date:  2013-01-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.